Research ArticleHuman Studies
Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations
John M.H. de Klerk, Alfred D. van het Schip, Bernard A. Zonnenberg, Aalt van Dijk, Marcel P.M. Stokkel, Shiuw H. Han, Geert H. Blijham and Peter P. van Rijk
Journal of Nuclear Medicine September 1994, 35 (9) 1423-1428;
John M.H. de Klerk
Alfred D. van het Schip
Bernard A. Zonnenberg
Aalt van Dijk
Marcel P.M. Stokkel
Shiuw H. Han
Geert H. Blijham


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations
John M.H. de Klerk, Alfred D. van het Schip, Bernard A. Zonnenberg, Aalt van Dijk, Marcel P.M. Stokkel, Shiuw H. Han, Geert H. Blijham, Peter P. van Rijk
Journal of Nuclear Medicine Sep 1994, 35 (9) 1423-1428;
Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations
John M.H. de Klerk, Alfred D. van het Schip, Bernard A. Zonnenberg, Aalt van Dijk, Marcel P.M. Stokkel, Shiuw H. Han, Geert H. Blijham, Peter P. van Rijk
Journal of Nuclear Medicine Sep 1994, 35 (9) 1423-1428;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Phase 2 Study of a High Dose of 186Re-HEDP for Bone Pain Palliation in Patients with Widespread Skeletal Metastases
- The Placorhen Study: A Double-Blind, Placebo-Controlled, Randomized Radionuclide Study with 186Re-Etidronate in Hormone-Resistant Prostate Cancer Patients with Painful Bone Metastases
- Quantitative Bone Single-Photon Emission Computed Tomography for Prediction of Pain Relief in Metastatic Bone Disease Treated With Rhenium-186 Etidronate
- Rhenium-186-labeled Hydroxyethylidene Diphosphonate Dosimetry and Dosing Guidelines for the Palliation of Skeletal Metastases from Androgen-independent Prostate Cancer